The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 to 100 years
• All sexes
• No healthy volunteers
• Adult, Older adult

Study population: Patients with coronary artery disease undergoing a rotational atherectomy in coronary lesion/s

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

About this study

Official title: A Prospective Follow-up Assessment in Bad Segeberg With Patients Undergoing a Rotational Atherectomy in Coronary Lesion/s

Conditions

Coronary Artery Disease

Being tested

Rotational Atherectomy in Coronary Lesion/s

Keywords

Calcified coronary artery lesions

Medical subject headings

Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Rotational Atherectomy in Coronary Lesion/sProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Rate of in-hospital and long-term cardiovascular adverse events in percent

   Peri-procedural events and in-hospital cardiovascular events and long-term cardiovascular events (bleeding, peripheral and coronary vascular complication, stroke, myocardial infarction, stent thrombosis, revascularization, death)

   Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted8 Jul 2019
2. Study start25 Nov 2002
3. Primary completion31 Dec 2030 (estimated)
4. Study completion31 Dec 2032 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Coronary Artery DiseaseStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.